The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and activity of CLN-081 (TAS6417) in NSCLC with EGFR Exon 20 insertion mutations (Ins20).
 
Zofia Piotrowska
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; C4 Therapeutics; Genentech; Guardant Health; Incyte; Janssen; Jazz Pharmaceuticals; Lilly; Medtronic; Takeda
Research Funding - Abbvie (Inst); ARIAD/Takeda (Inst); AstraZeneca (Inst); Cullinan Oncology (Inst); Daiichi Sankyo Europe GmbH (Inst); Johnson & Johnson (Inst); Novartis (Inst); Spectrum Pharmaceuticals (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genentech
 
Helena Alexandra Yu
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Daiichi Sankyo; Janssen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Cullinan Oncology (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Lilly
Other Relationship - Astellas Pharma
 
James Chih-Hsin Yang
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Ono Pharmaceutical; Pfizer; Roche; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Amgen; Astellas Pharma; AstraZeneca; AstraZeneca (Inst); Bayer; Blueprint Medicines; Boehringer Ingelheim; Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Celgene; Clovis Oncology; Daiichi Sankyo; G1 Therapeutics; Hansoh; Incyte; Lilly; Merck Serono; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Roche/Genentech; Takeda; Yuhan
Travel, Accommodations, Expenses - Pfizer
 
Marianna Koczywas
Speakers' Bureau - AstraZeneca; Celgene
 
Egbert F. Smit
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Merck KGaA (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Takeda (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
 
Daniel Shao-Weng Tan
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Loxo; Merck; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer; Roche
 
Victor Ho-Fun Lee
Honoraria - Amgen; AstraZeneca; Lilly; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Lilly; Merck Sharp & Dohme; Pfizer; Roche
Speakers' Bureau - Amgen; AstraZeneca; Lilly; Pfizer; Roche
Research Funding - AstraZeneca; Pfizer
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Merck Sharp & Dohme; Pfizer
 
Ross A. Soo
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck; Novartis; Pfizer; Roche/Genentech; Takeda; Yuhan
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck; Novartis; Pfizer; Roche/Genentech; Taiho Pharmaceutical; Takeda; Yuhan
Research Funding - AstraZeneca; Boehringer Ingelheim
 
John M. Wrangle
Employment - Precision Genetics
Leadership - Precision Genetics
Stock and Other Ownership Interests - Precision Genetics
 
Alexander I. Spira
Stock and Other Ownership Interests - Lilly
Honoraria - Amgen; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Janssen Oncology; Merck; Novartis; Takeda
Consulting or Advisory Role - Amgen; Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Gritstone Bio; incyte; Jazz Pharmaceuticals; Merck (Inst); Mirati Therapeutics; Novartis
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); ADC Therapeutics (Inst); Amgen (Inst); Arch Therapeutics (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Gritstone Bio (Inst); Ignyta (Inst); Incyte (Inst); Janssen Oncology (Inst); LAM Therapeutics; LAM Therapeutics (Inst); Loxo (Inst); Loxo (Inst); Macrogenics (Inst); MedImmune (Inst); Mirati Therapeutics (Inst); Newlink Genetics (Inst); Novartis (Inst); Plexxikon (Inst); Roche (Inst); Rubius Therapeutics (Inst); Takeda (Inst); Trovagene (Inst)
 
Vamsidhar Velcheti
Consulting or Advisory Role - AstraZeneca/MedImmune; Boston Scientific; Bristol-Myers Squibb; EMD Serono; Foundation Medicine; GlaxoSmithKline; Lilly; Merck; Novartis; Novocure
Research Funding - Alkermes (Inst); Altor BioScience (Inst); Atreca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Genoptix (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Leap Therapeutics (Inst); Merck (Inst); NantWorks (Inst); OncoPlex Diagnostics (Inst); RSIP Vision (Inst); Trovagene (Inst)
 
Mark A. Socinski
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Genentech; Guardant Health; Lilly; Merck; Roche/Genentech
Consulting or Advisory Role - AstraZeneca/MedImmune; Genentech; Janssen; Lilly; Novartis
Speakers' Bureau - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Merck
Research Funding - AstraZeneca/MedImmune (Inst); Genentech (Inst); Spectrum Pharmaceuticals (Inst)
 
Asher Page
Employment - Cullinan Management
Stock and Other Ownership Interests - Cullinan Management
 
David Witter
Employment - Cullinan Oncology
Stock and Other Ownership Interests - AstraZeneca; Cullinan Oncology; Curis; Merck; Pfizer
 
Leigh Zawel
Employment - Cullinan Oncology
Leadership - Cullinan Oncology
Stock and Other Ownership Interests - Cullinan Oncology
Patents, Royalties, Other Intellectual Property - Cullinan Oncology
Travel, Accommodations, Expenses - Cullinan Oncology
 
Jon M. Wigginton
Employment - Cullinan Oncology; MacroGenics
Leadership - Cullinan Oncology; Sutro Biopharma
Stock and Other Ownership Interests - Cullinan Oncology; Harbour BioMed; MacroGenics; Refuge Biotech; Sutro Biopharma
Consulting or Advisory Role - Gossamer Bio; Harbour BioMed; IO Biotech; MPM Capital; Refuge Biotech; Western Oncolytics
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb; MacroGenics
 
Myles Steven Clancy
Employment - Cullinan Oncology
Stock and Other Ownership Interests - Cullinan Oncology
Patents, Royalties, Other Intellectual Property - Cullinan Oncology
 
Danny Nguyen
Employment - Pacific Shores Medical Group
Stock and Other Ownership Interests - Intuitive Surgical; Teladoc